Clinical Trial Update: ZR-CHOP in DLBCL With Specific Gene Abnormality [Phase 2]

View source ↗

Summary

Phase 2 trial update of ZR-CHOP in diffuse large B-cell lymphoma with a specific gene abnormality.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• ZR-CHOP

Snippet

Sponsor: Fudan University | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN